The FDA’s surprise approval of Novartis’ generic version of the blood thinner Lovenox after a four-year review is a signal the FDA may be more willing to approve complex generic products in the coming years, says Jeffrey George, global head of Novartis’s Sandoz generic drug unit.
“It underscores that the FDA really does have the institutional [...]
company cost health insurance low orlando